EAM Global Investors’s NeoGenomics NEO Stock Holding History

EAM Global Investors’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-206,574	Closed	-$3.6M	–	109
2023 Q1	$3.6M	Buy	+206,574	New	+$2.94M	1.01%	62
2019 Q3	–	Sell	-109,933	Closed	-$2.41M	–	143
2019 Q2	$2.41M	Hold	109,933	–	–	1.03%	23
2019 Q1	$2.25M	Hold	109,933	–	–	1%	21
2018 Q4	$1.39M	Hold	109,933	–	–	0.76%	62
2018 Q3	$1.69M	Hold	109,933	–	–	0.68%	46
2018 Q2	$1.44M	Buy	+109,933	New	+$1.21M	0.7%	46

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM Global Investors's NEO Position: Q2 2023 in Review

EAM Global Investors sold out of NeoGenomics (NEO) in Q2 2023, closing a stake of 206,574 shares — an estimated $3.6M sold.

EAM Global Investors first reported a position in NEO in Q2 2018 and held it in 6 quarters. The position peaked at $3.6M in Q1 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2023.

EAM Global Investors reported no remaining NeoGenomics position as of Q2 2023 after selling out during the quarter.
EAM Global Investors sold 206,574 NeoGenomics shares in Q2 2023, an estimated $3.6M.
EAM Global Investors first reported a position in NeoGenomics in Q2 2018 and held it in 6 quarters.
EAM Global Investors's NeoGenomics position peaked at $3.6M in Q1 2023.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2023.

Based on EAM Global Investors's 13F filing for Q2 2023, filed 11 Aug 2023.